T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.37% |
| 2 | Financials | 13.66% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Technology | 10.86% |
| 5 | Industrials | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Xerox
XRX
$407M
| $18.9M | ﹤0.01% |
674,972
-11,449,902
| -94% | -$354M |
|
1152
Waters Corp
WAT
$40.5B
| $18.8M | ﹤0.01% |
146,556
+5,190
| +4% | +$673K |
|
1153
NVIDIA
NVDA
$5.45T
| $18.6M | ﹤0.01% |
37,060,640
+704,000
| +2% | +$382K |
|
|
SWNC
1154
DELISTED
Southwestern Energy Company
SWNC
| $18.6M | ﹤0.01% |
378,050
+4,000
| +1% | +$222K |
|
1155
Insteel Industries
IIIN
$634M
| $18.6M | ﹤0.01% |
992,850
+1,900
| +0.2% | +$38.8K |
|
|
ISIL
1156
DELISTED
Intersil Corp
ISIL
| $18.5M | ﹤0.01% |
1,481,682
-5,900
| -0.4% | -$80.5K |
|
|
JWN
1157
DELISTED
Nordstrom
JWN
| $18.4M | ﹤0.01% |
247,119
+2,700
| +1% | +$205K |
|
1158
PRA Group
PRAA
$778M
| $18.3M | ﹤0.01% |
293,850
-2,800
| -0.9% | -$161K |
|
1159
Supernus Pharmaceuticals
SUPN
$2.78B
| $18.2M | ﹤0.01% |
1,074,249
+12,799
| +1% | +$182K |
|
|
PRXL
1160
DELISTED
Parexel International Corp
PRXL
| $18.1M | ﹤0.01% |
281,507
+19,500
| +7% | +$1.31M |
|
|
CAA
1161
DELISTED
CalAtlantic Group, Inc.
CAA
| $18M | ﹤0.01% |
404,956
-740
| -0.2% | -$31.5K |
|
1162
MaxLinear
MXL
$7.54B
| $18M | ﹤0.01% |
1,485,426
+3,596
| +0.2% | +$36.1K |
|
|
EGL
1163
DELISTED
Engility Holdings, Inc.
EGL
| $18M | ﹤0.01% |
713,740
+78,296
| +12% | +$2.22M |
|
1164
U-Haul Holding Co
UHAL
$14.4B
| $17.9M | ﹤0.01% |
547,000
-29,000
| -5% | -$948K |
|
|
SMRT
1165
DELISTED
Stein Mart Inc
SMRT
| $17.9M | ﹤0.01% |
1,705,299
-1,200,600
| -41% | -$13.8M |
|
|
PTLA
1166
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $17.8M | ﹤0.01% |
390,779
-18,300
| -4% | -$736K |
|
1167
Kosmos Energy
KOS
$1.53B
| $17.8M | ﹤0.01% |
2,109,519
+2,080,122
| +7,076% | +$18.5M |
|
1168
Larimar Therapeutics
LRMR
$447M
| $17.7M | ﹤0.01% |
42,633
-1,747
| -4% | -$731K |
|
|
CTRL
1169
DELISTED
Control4 Corporation
CTRL
| $17.6M | ﹤0.01% |
1,982,552
-1,046,990
| -35% | -$10.8M |
|
1170
ON Semiconductor
ON
$31.9B
| $17.5M | ﹤0.01% |
1,498,540
-3,349,760
| -69% | -$41.1M |
|
1171
MACOM Technology Solutions
MTSI
$23.8B
| $17.5M | ﹤0.01% |
457,060
-97,630
| -18% | -$3.6M |
|
1172
Travel + Leisure Co
TNL
$4.64B
| $17.4M | ﹤0.01% |
470,665
+14,198
| +3% | +$556K |
|
1173
FMC
FMC
$1.29B
| $17.4M | ﹤0.01% |
381,403
+1,383
| +0.4% | +$68.7K |
|
1174
World Kinect Corp
WKC
$1.86B
| $17.4M | ﹤0.01% |
361,895
+91,295
| +34% | +$4.78M |
|
|
HNT
1175
DELISTED
HEALTH NET INC
HNT
| $17.3M | ﹤0.01% |
270,530
+246,900
| +1,045% | +$14.8M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.